-VISIT OUR OTHER FORUMS- OB-GYN-L Ultrasound Ultrasound History Fibroid Forum Physicians-in-Training Tech Talk OBSTET-L (portuguese) OBGIN-L (spanish) Nursing

Re: Maternal deaths, and risk of misoprostol for missed AB From: Gerald P. Rodríguez (geraldpr@cybermesa.com) Sat Mar 18 15:50:26 2006 Messages sorted by: [ date ][ thread ][ subject ][ author ] Next message: Raymond Stephen: "Re: Maternal deaths, and risk of misoprostol for missed AB" Previous message: Betsy Hyde: "Re: Maternal deaths, and risk of misoprostol for missed AB" Maybe in reply to: igold@cox.net: "Maternal deaths, and risk of misoprostol for missed AB" Next in thread: Raymond Stephen: "Re: Maternal deaths, and risk of misoprostol for missed AB" You are correct; I believe I miss-read the WSJ article. Gerald P. Rodríguez, M.D., FACOG Santa Fe >----- Original Message ----- From: "Betsy Hyde" <elishyde@mindspring.com> To: "Multiple recipients of list OB-GYN-L" <ob-gyn-l@dns.obgyn.net> Sent: Saturday, March 18, 2006 3:32 PM Subject: Re: Maternal deaths, and risk of misoprostol for missed AB > The RU-486 was given orally. Part 2, the misoprostil, was given off > label intravaginally. This is a difference between Planned Parenthood and > FDA. The women had septic abs d/t clostridia. > > Betsy Hyde CNM > Branford, CT > > On Mar 18, 2006, at 1:16 PM, Gerald P. Rodríguez wrote: > >> Today's Wall Street Journal reports that Planned Parenthood in >> Washington DC said yesterday that it was changing its prescribing >> practices for the use of MIFEPRISTONE (Mifprex) (RU-486) in light of two >> recent maternal deaths associated with its use vaginally instead of >> orally. Its vaginal use is off-label and this practice is now being >> implicated in the death of 6 total patients from sepsis. >> >> Gerald P. Rodríguez, M.D., FACOG >> Santa Fe >> >> ~~~~~~~~~~~~~ >> Quien calla otorga. >> ~~~~~~~~~~~~~~ >> ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ >>> ----- Original Message ----- From: <igold@COX.NET> >> To: "Multiple recipients of list OB-GYN-L" <ob-gyn-l@dns.obgyn.net> >> Sent: Saturday, March 18, 2006 9:58 AM >> Subject: Maternal deaths, and risk of misoprostol for missed AB >> >>> In light of the recent news linking maternal deaths to use of vaginal >>> administation of misoprostol, what do you think of continuing its use >>> for missed AB? Do you think oral administation would reduce the risk? >>> Why? From what I understand, 6 maternal deaths have now been attributed >>> to vaginal use of misoprostol (my sources are NPR driving home from >>> work last night, and this morning's Arizona Republic newspaper) Thanks, >>> Ingrid Gold, CNM, Phoenix >> > Next message: Raymond Stephen: "Re: Maternal deaths, and risk of misoprostol for missed AB" Previous message: Betsy Hyde: "Re: Maternal deaths, and risk of misoprostol for missed AB" Maybe in reply to: igold@cox.net: "Maternal deaths, and risk of misoprostol for missed AB" Next in thread: Raymond Stephen: "Re: Maternal deaths, and risk of misoprostol for missed AB"

Return to

Mail a New Message to the Forum: ob-gyn-l@obgyn.net Forum Administrator: geffrey.klein@obgyn.net Report Technical Problems: webmaster@obgyn.net Last Updated: Wed Dec 2 05:04:28 2009

The American Medical Association is no longer designating CME hours for AMA Category II CME credit. However, physicians themselves may self designate learning activities as Category II CME credit hours if they feel it is of sufficient educational merit and meets the formal definitions of continuing medical education. OBGYN.net believes these interaction in this forum meets these criteria. For further information see the AMA web site.